Meena B. Bansal - Researcher Profile

Publications

2 shown

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison , Pierre Bédossa , Cynthia D. Guy +26 more

Both the 80-mg dose and the 100-mg dose of resmetirom were superior to placebo with respect to NASH resolution and improvement in liver fibrosis by at least one stage. (Funded b...

2024 New England Journal of Medicine 1238 citations

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi , Vlad Ratziu , Rohit Loomba +97 more

2019 The Lancet 1142 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,380
Institution: Icahn School of Medicine at Mount Sinai

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7501-2191

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.